NEW YORK (GenomeWeb News) – The prenatal genetic testing company Cellscape said that Ted Snelgrove has become its new CEO, effective last week.

Snelgrove previously was VP of sales and marketing for Genomic Health, where he led the commercial development and launch of the Oncotype Dx test. He most recently was chief commercial officer for Crescendo Bioscience, and he has worked in business development, marketing, and product management at Amgen, ALZA, Immunex, and Eli Lilly.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.